On the other hand, due to the multiple anti-inflammatory activities, TGF-β1 is thought to inhibit several aspects of the immune response, and this cytokine could have an immune-down-regulatory role in the pathophysiology of chronic progressive multiple sclerosis [27]. The gene discussed is TGFB1; the disease is chronic progressive multiple sclerosis.